Skip to main content
Imran Siddiqi, MD, Pathology, Los Angeles, CA

Imran N Siddiqi MD

Hematopathology, Anatomic Pathology, Clinical Pathology


Assistant Professor, Pathology, USC School of Medicine

Join to View Full Profile
  • 2011 Zonal Ave# HmrLos Angeles, CA 90089

  • Phone+1 323-442-2582

  • Fax+1 323-442-2588

Dr. Siddiqi is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
  • Connect with colleagues in the same hospital or clinic.
  • Read the latest clinical news, personalized to your specialty.

Summary

  • Dr. Imran Siddiqi is a pathologist in Los Angeles, CA and is affiliated with multiple hospitals in the area, including Keck Hospital of USC, Los Angeles Community Hospital at Los Angeles, and USC Norris Comprehensive Cancer Center. He received his medical degree from University of California Irvine School of Medicine and has been in practice 15 years. He specializes in hematopathology, anatomic pathology, and clinical pathology.

Education & Training

  • University of California (San Francisco)
    University of California (San Francisco)Fellowship, Hematopathology, 2006 - 2007
  • University of California (San Francisco)
    University of California (San Francisco)Residency, Pathology-Anatomic and Clinical, 2002 - 2006
  • University of California, Irvine, School of Medicine
    University of California, Irvine, School of MedicineClass of 2002

Certifications & Licensure

  • CA State Medical License
    CA State Medical License 2004 - 2025
  • Pathology - Anatomic/Pathology - Clinical
    American Board of Pathology Pathology - Anatomic/Pathology - Clinical
  • Hematopathology
    American Board of Pathology Hematopathology

Publications & Presentations

PubMed

Abstracts/Posters

  • Highly Multiplexed Single Cell Spatial Analysis of the Tumor Microenvironment in Lymphoma Predicts Clinical Outcomes
    Imran Siddiqi, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/8/2019

Press Mentions

  • Deadliest Cancers May Respond to New Drug Treatment Strategy
    Deadliest Cancers May Respond to New Drug Treatment StrategyJanuary 29th, 2016

Viewing the full profile is available to verified healthcare professionals only.

Find your profile and take control of your online presence: